Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




U.S. FDA Staff Note Deaths in Pfizer Bone Drug Study
Link ID 8398
Title U.S. FDA Staff Note Deaths in Pfizer Bone Drug Study
Url http://www.medscape.com/viewarticle/580074?src=rss
Description Osteoporosis patients who received a low dose of an experimental Pfizer Inc pill were more likely to die within five years than others who got a placebo, U.S. drug reviewers said in an analysis released on Thursday. Reuters Health Information
Category Articles > Business of Medicine
Keywords
Date Sep 5, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Business of Medicine
1. Allergan Gets Subpoena on Botox Promotion
  Allergan Inc said on Monday that it received a subpoena from the U.S. Department of Justice investigating the promotion of Botox. Reuters Health Information
Category:   Articles > Business of Medicine


2. Patients, Caregivers, and the Danger of Imaging Studies: The Four Horsemen of the Radiology Apocalyp
  The subject of radiation-induced cancer from CT is controversial, and is disputed, primarily by radiologists, citing lack of scientific evidence. Medscape Radiology
Category:   Articles > Business of Medicine


3. DEA Suspends a Cardinal Substance-Control License
  Drug wholesaler Cardinal Health Inc said yesterday the U.S. Drug Enforcement Administration will suspend its license to distribute controlled substances from its Auburn, Washington, facility due to a failure to properly oversee hydrocodone sales. Reuters Health Information
Category:   Articles > Business of Medicine


4. What Broke Me
  On a medical mission to an impoverished country, a medical student experiences the human toll of healthcare disparities.
Medscape Med Students
Category:   Articles > Business of Medicine


5. Abbott Labs and Solvay Sued in 18 States for Monopoly Efforts With TriCor
  Abbott and two units of Solvay SA are accused of undermining efforts to bring generic drugs to market by patenting new formulations of TriCor with only minor changes to the drug. Heartwire
Category:   Articles > Business of Medicine




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS